Crossref
Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review
Clinical Oncology · 2026-03 · 51 · 104017
DOI: 10.1016/j.clon.2025.104017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology, 2026-03. Verfasst von Estabrak Jiad und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jiad, E., Westbury, C., & Shah, N. (2026). Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review. Clinical Oncology, 51, 104017. https://doi.org/10.1016/j.clon.2025.104017
Vancouver
Jiad E, Westbury C, Shah N. Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review. Clinical Oncology. 2026;51:104017. doi:10.1016/j.clon.2025.104017
BibTeX
@article{Jiad2026,
author = {Jiad, Estabrak and Westbury, Charlotte and Shah, Nihal},
title = {Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review},
journal = {Clinical Oncology},
year = {2026},
volume = {51},
pages = {104017},
doi = {10.1016/j.clon.2025.104017}
}
EUVIMED